For instance, metformin treatment enhances the expression of NKG2D ligands (RAE-1 and MULT-1) and DNAM-1 ligands (PVR/CD155) on multiple myeloma (MM) cells, thereby increasing NK cell recognition and cytotoxicity against tumor cells (Molfetta et al., 2019). This evidence concerns the gene PVR and AL amyloidosis.